Homeopathy Papers

The Role of Homeopathy in Integrative Cancer Care

Dr. Arup Bhattacharya and Yuesh Zhang discuss the Role of homeopathy in Integrative Cancer Care.

Department of Chemoprevention, Roswell Park Cancer Institute, Buffalo, NY 14263, United States

*Corresponding author: Bhattacharya A, Department of Chemoprevention, Roswell Park Cancer Institute, Elm and Carton Streets, Buffalo, NY 14263, USA, Tel: 716-845-4944; Fax: 716-845-1144; E-mail: [email protected]

Received date: December 24, 2015; Accepted date: December 26, 2015; Published date: December 28, 2015

Copyright: © 2015, Bhattacharya A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Keywords: Homeopathy; Cancer care

Cancer has proven to be a relentless foe in exploiting alternate pathways to resistance to conventional therapies. Cancer patients and survivors often seek alternative approaches while receiving conventional treatments, in the hope of achieving better outcomes in fighting the primary disease, preventing recurrence and improving end of life palliation. Homeopathy is one of such approaches, which was started by physicians in the 19th century based on the theory that any substance that can produce symptoms of disease or illness in a healthy person can cure those symptoms in a sick person using a highly diluted succussed solution (>Avogadro’s number or 6.023 × 1023).

In the US, homeopathy is part of the complementary and alternative medicine (CAM) accounting for a $9 billion market each year [1], with over five million adults and one million children using homeopathy annually [2]. Among the 236 European centers that provide integrative oncology services in the public health system, homeopathy is one of the leading CAM therapies [3]. However, most patients would not discuss their CAM needs or use with their conventional health professionals due to concerns about health professionals’ lack of knowledge or interest or fear of negatively impacting their relationship with their health professionals [4]. There is a need for further investigating and possibly integrating feasible and effective alternatives including homeopathic medicines into conventional approaches. Notably, the National Cancer Institute (NCI) Best Case Series Program which invited CAM practitioners treating cancer patients to present data concluded after rigorous evaluations that there was sufficient evidence of a possible efficacy of homeopathic medicine in cancer and that homeopathy warrants further research [5-7].

Despite widespread negative views in the scientific community and within the general population at large, many clinical, preclinical and in vitro studies indicate the presence of evidence for homeopathy. Homeopathic prophylactic oral formulation for mass immunization using four strains of Leptospirosis administered to 2.3 million people in a region of high risk of an epidemic in Cuba in 2007 was found to be effective in significantly decreasing the disease incidence [8,9]. Homeopathic treatment alone using Ruta was found to be effective in brain cancer patients with either remission or partial regression [10]. The same study also found that homeopathic Ruta can selectively induce cell death in human malignant glioma MGR1, human promyelomonocytic leukemia cell line HL-60, and murine metastatic melanoma K1735 clone X-21, while not adversely affecting proliferation of normal blood lymphocytes [10]. Extended survival time in cancer patients with a fatal prognosis such as with glioblastoma, lung, cholangiocellular and pancreatic carcinomas, metastasized sarcoma, and renal cell carcinoma was noted with additive homeopathic treatment in a study with a small sample size [11]. A randomized placebo-controlled trial (RCT) with a sample size of >1000 patients of hay fever found the use of homeopathic Galphimia glauca to be significantly superior over placebo and with success rates similar to conventional antihistamines, but with no side effects [12].

Homeopathy was found to be beneficial in improving quality of life and reducing fatigue and improving Functional Assessment of Chronic Illness Therapy for Cancer scores in cancer patients [13,14]. A significant improvement in the symptoms of the cancer or of the adverse effects of the conventional anticancer therapies such as nausea, insomnia, depression, anxiety, asthenia and hot flushes was seen at a homeopathic clinic funded by the Tuscany Region in Lucca, Italy [15]. Homeopathic Arsenicum album was shown to be effective in reducing arsenic poisoning in humans [16,17]. Homeopathy in an integrative approach with conventional medicine has been reported to be used in treating HIV/AIDS in East Africa [18]. A meta-analysis indicated that the clinical effects of homeopathy are not purely due to the placebo effect [19]. Others have also reported specific non-placebo treatment effects [20-23]. Similar positive results were inferred from various RCTs and other studies on homeopathy [24,25]. However, RCTs of individualized homeopathic treatment have to be of a much better quality in order to withstand the critics who equate homeopathy at best with placebo effect [26-28].

Conclusion and interpretation vary depending often on what one is willing to accept as scientific information [29] and further, as a result of bias in the scientific community against homeopathy, it is often easier to publish negative results on homeopathy in the peer-reviewed literature than positive ones [30]. Lack of mechanistic insights has often plagued homeopathy studies, such as the unexplained findings that homeopathic dilutions of anti-IgE antibodies cause human basophil degranulation [31] and homeopathic dilutions of histamine inhibit basophil activation [32].

In animal studies, homeopathic Ruta graveolens and Hydrastis canadensis led to a 95.6% and 95.8% tumor reduction of Ehrlich Ascites Carcinoma and Dalton’s Lymphoma Ascites (DLA) and were found to increase the lifespan of the tumor-bearing animals by 49.7%, and 69.4% respectively [33]. The same study reported that homeopathic Hydrastis administered orally significantly inhibited the growth of DLA tumors, with 9 out of 15 tumor bearing animals achieving complete tumor remission. There was significant antimetastatic activity in B16F-10 melanoma-bearing animals treated with homeopathic Thuja, Hydrastis and Lycopodium [33]. Homeopathic Sabal serrulata significantly decreased the proliferation of human prostate cancer PC-3 cells and DU-145 cells and significantly decreased prostate tumor xenograft growth in mice [34]. Homeopathic Ruta, Hydrastis, Lycopodium, Thuja, Chelidonium, Natrum sulphuricum, Cholesterinum and Carcinosinum were found to exhibit immunomodulatory effects while inhibiting chemically induced carcinogenesis [35,36] and hepatotoxicity in rats and mice [37-39]. Homeopathic Condurango was found to modulate certain pro- and anti-apoptotic genes related to a caspase-3-mediated apoptotic pathway in benzopyrene-induced lung tumors in rats [40,41].

In vitro, homeopathic Carcinosin, Phytolacca, Conium and Thuja were found to be cytotoxic to breast adenocarcinoma cell lines MCF-7 and MDA-MB-231, causing cell cycle delay/arrest and apoptosis [42]. Homeopathic Thuja was found to significantly ameliorate benzopyrene-induced DNA damage in perfused normal lung cells of mice [43]. Homeopathic Condurango caused G1-phase cell-cycle arrest, a reduction in histone deacytylase 2 activity and DNA synthesis, and was also found to induce epigenetic modifications and alter gene expression profile in cervical cancer HeLa cells [44,45]. Homeopathic Conium maculatum, Sabal serrulata, Thuja occidentalis, Asterias, Phytolacca, and Carcinosin were found to have no measurable effects on expression of cell growth- or apoptosis- related genes in prostate cancer cell lines (DU-145, LNCaP, MAT-LyLu) and breast cancer cell line MDA-MB-231 [46]. However, homeopathic Gelsemium sempervirens was able to change the expression of 56 genes, of which 49 were down-regulated and 7 were overexpressed in human SH-SY5Y neuroblastoma cells; some of the down-regulated genes belong to G-protein coupled receptor signaling pathways, calcium homeostasis, inflammatory response and neuropeptide receptors [47]. Others have reported that although homeopathic treatment significantly slows cancer progression in vivo with a reduction in cancer incidence and mortality [48], there is no distinct effect of the same homeopathic medicine on cancer cells in vitro and no alterations of gene expression related to apoptosis or cytokines [49] in the tumor tissues mentioned above.

Recent insights into the potential mechanism of action of the scientifically implausible homeopathic ultra-dilutions are based on evidence of presence of nanoparticles of the original substance persisting across all potencies of a homeopathic medicine even those beyond the theoretical Avogadro’s limit [50-52]. Presence of the starting raw materials in nanoparticulate form has been unequivocally confirmed in very high dilutions such as >1023 dilutions. Chikramane et al showed that once the bulk concentration is below a threshold level of a few ng/ml all of the nanoparticles levitate to the surface and are accommodated as a monolayer at the top where it is preserved and carried to the subsequent step, thereby forming an asymptotic concentration. Thus, they claim that all dilutions are only apparent and not real in terms of the concentrations of the starting raw materials [53]. The specific nanoparticle of the starting substance in homeopathic form may treat infections via improved bioavailability and have anti-inflammatory, antioxidant, and immunomodulatory effects [54]. A potentised substance may also change its own pharmacological effects while modulating host response [55].

Homeopathy was under the spotlight when Dr. Luc Montagnier, the discoverer of HIV virus, reported on high dilutions (i.e., 1010 and 1012 dilutions) of bacterial and viral DNA sequence that form specific nanostructures which are responsible for the electro-magnetic signals that can transfer information [56].

In sum, finding safer and effective armamentarium against cancer remains an ongoing challenge. The recent discovery of the presence of nanoparticles in homeopathic medicines could provide the rationale and additional impetus for carrying out well-designed RCTs and preclinical studies in order to settle the question of efficacy of homeopathy in treating cancer and possibly being part of the future integrative medicine in offering safe and effective ways of combating cancer, as well as to understand the mechanism of action of such therapy.


  1. Davis MA, Martin BI, Coulter ID, Weeks WB (2013) US spending on complementary and alternative medicine during 2002-08 plateaued, suggesting role in reformed health system. Health Aff (Millwood) 32: 45-52.
  2. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL (2015) Trends in the use of complementary health approaches among adults: United States,2002-2012. Natl Health Stat Report 10: 1-16.
  1. Rossi E, Vita A, Baccetti S, Di Stefano M, Voller F, et al. (2015) Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe. Support Care Cancer 23: 1795-1806.
  1. Adler SR, Fosket JR (1999) Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract 48: 453-458.
  1. Olaku O, Zia F, Santana JM, White JD (2013) The National Cancer Institute best case series program: a summary of cases of cancer patients treated with unconventional therapies in India. Integr Cancer Ther 12: 385-392.
  1. Banerji P, Campbell DR, Banerji P (2008) Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: a Best Case Series Program of the National Cancer Institute USA. Oncol Rep 20: 69-74.
  1. Vanchieri C (2000) Alternative therapies getting notice through Best Case Series Program. J Natl Cancer Inst 92: 1558-1560.
  1. Bracho G, Varela E, Fernández R, Ordaz B, Marzoa N, et al. (2010) Largescale application of highly- diluted bacteria for Leptospirosis epidemic control. Homeopathy 99: 156-166.
  1. Golden I, Bracho G2 (2014) A Reevaluation of the Effectiveness of Homoeoprophylaxis Against Leptospirosis in Cuba in 2007 and 2008. J Evid Based Complementary Altern Med 19: 155-160.
  1. Pathak S, Multani AS, Banerji P, Banerji P (2003) Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer. Int J Oncol 23: 975-982.
  1. Gaertner K, Mullner M, Friehs H, Schuster E, Marosi C, et al. (2014) Additive homeopathy in cancer patients: Retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna. Complement Ther Med 22: 320-332.
  1. Lüdtke R, Wiesenauer M (1997) A meta-analysis of homeopathic treatment of pollinosis with Galphimia glauca. Wien Med Wochenschr 147: 323-327.
  1. Rostock M, Naumann J, Guethlin C, Guenther L, Bartsch HH, et al.(2011) Classical homeopathy in the treatment of cancer patients—a prospective observational study of two independent cohorts. BMC Cancer 11: 19.
  1. Poole J (2014) Individualised homeopathy after cancer treatment. Nurs Times 110: 17-19.
  2. Rossi E, Picchi M, Panozzo M, Di Stefano M, Baccetti S (2015) Integration of homeopathy and complementary medicine in the public health system in Italy: national regulation and regional experiences. J Med Pers 13: 45-54.
  1. Khuda-Bukhsh AR, Banerjee A, Biswas SJ, Karmakar SR, Banerjee P, et al.(2011) An initial report on the efficacy of a millesimal potency Arsenicum Album LM 0/3 in ameliorating arsenic toxicity in humans living in a high-risk arsenic village. Zhong Xi Yi Jie He Xue Bao 9: 596-604.
  1. Khuda-Bukhsh AR, Roy-Karmakar S, Banerjee A, Banerjee P, Pathak S, et al. (2011) A Follow-Up Study on the Efficacy of the Homeopathic Remedy Arsenicum album in Volunteers Living in High Risk Arsenic Contaminated Areas. Evid Based Complement Alternat Med 2011:129214.
  1. Quirk T, Sherr J (2015) Experiences with an integrative approach to treating HIV/AIDS in East Africa. J Med Pers 13: 55-64.
  1. Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, et al. (1997) Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 350: 834-843.
  1. Cucherat M, Haugh MC, Gooch M, Boissel JP (2000) Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group. Eur J Clin Pharmacol 56: 27-33.
  1. Mathie RT, Clausen J (2015) Veterinary homeopathy: meta-analysis of randomised placebo controlled trials. Homeopathy 104: 3-8.
  1. Mathie RT, Lloyd SM, Legg LA, Clausen J, Moss S, et al. (2014) Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis. Syst Rev 3: 142.
  1. Riley D, Fischer M, Singh B, Haidvogl M, Heger M (2001) Homeopathy and conventional medicine: an outcomes study comparing effectiveness in a primary care setting. J Altern Complement Med 7: 149- 159.
  1. Taylor MA, Reilly D, Llewellyn-Jones RH, McSharry C, Aitchison TC (2000) Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ 321: 471-476.
  1. Bellavite P, Ortolani R, Pontarollo F, Piasere V, Benato G, et al. (2006) Immunology and homeopathy.
  2. Clinical studies-part 2. Evid Based Complement Alternat Med 3: 397-409.
  3. Goldacre B (2007) Benefits and risks of homoeopathy. Lancet 370: 1672-1673.
  4. Ernst E (2007) Homeopathy for cancer? Curr Oncol 14: 128-130.
  5. Ernst E (2008) The truth about homeopathy. Br J Clin Pharmacol 65: 163-164.
  6. Pittler MH, Abbot NC, Harkness EF, Ernst E (2000) Location bias in controlled clinical trials of complementary/alternative therapies. J Clin Epidemiol 53: 485-489.
  1. Walach H, Jonas WB, Ives J, van Wijk R, Weingärtner O (2005) Research on homeopathy: state of the art. J Altern Complement Med 11: 813-829.
  1. Davenas E, Beauvais F, Amara J, Oberbaum M, Robinzon B, et al. (1988) Human basophil degranulation triggered by very dilute antiserum against IgE. Nature 333: 816-818.
  1. Belon P, Cumps J, Ennis M, Mannaioni PF, Roberfroid M, et al. (2004) Histamine dilutions modulate basophil activation. Inflamm Res 53:181-188.
  1. Es S, Kuttan G, Kc P, Kuttan R (2007) Effect of homeopathic medicines on transplanted tumors in mice. Asian Pac J Cancer Prev 8: 390-394.
  1. MacLaughlin BW, Gutsmuths B, Pretner E, Jonas WB, Ives J, et al. (2006) Effects of homeopathic preparations on human prostate cancer growth in cellular and animal models. Integr Cancer Ther 5: 362-372.
  1. Kumar KB, Sunila ES, Kuttan G, Preethi KC, Venugopal CN, et al. (2007) Inhibition of chemically induced carcinogenesis by drugs used in homeopathic medicine. Asian Pac J Cancer Prev 8: 98-102.
  1. Remya V, Kuttan G (2015) Homeopathic remedies with antineoplastic properties have immunomodulatory effects in experimental animals.Homeopathy 104: 211-219.
  1. Banerjee A, Pathak S, Biswas SJ, Roy-Karmakar S, Boujedaini N, et al. (2010) Chelidonium majus 30C and 200C in induced hepato-toxicity in rats. Homeopathy 99: 167-176.
  1. Bhattacharjee N, Pathak S, Khuda-Bukhsh AR (2009) Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200. Evid Based Complement Alternat Med 6: 65-75.
  1. Bhattacharjee N, Khuda-Bukhsh AR (2012) Two homeopathic remedies used intermittently provide additional protective effects against hepatotoxicity induced by carcinogens in mice. J Acupunct Meridian Stud 5: 166-175.
  1. Sikdar S, Mukherjee A, Bishayee K, Paul A, Saha SK, et al. (2013) Post cancer Treatment with Condurango 30C Shows Amelioration of Benzo[a]pyrene-induced Lung Cancer in Rats Through the Molecular Pathway of Caspase-3-mediated Apoptosis Induction. J Pharmacopuncture 16: 11-22.
  1. Sikdar S, Mukherjee A, Khuda-Bukhsh AR (2014) Ethanolic Extract of Marsdenia condurango Ameliorates Benzo[a]pyrene-induced Lung Cancer of Rats: Condurango Ameliorates BaP-induced Lung Cancer in Rats. J Pharmacopuncture 17: 7-17.
  1. Frenkel M, Mishra BM, Sen S, Yang P, Pawlus A, et al. (2010) Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol 36: 395-403.
  1. Mukherjee A, Boujedaini N, Khuda-Bukhsh AR (2013) Homeopathic Thuja 30C ameliorates benzo(a)pyrene-induced DNA damage, stress and viability of perfused lung cells of mice in vitro . J Integr Med 11: 397-404.
  1. Bishayee K, Sikdar S, Khuda-Bukhsh AR1 (2013) Evidence of an Epigenetic Modification in Cell-cycle Arrest Caused by the Use of Ultrahighly diluted Gonolobus Condurango Extract. J Pharmacopuncture 16: 7-13.
  1. Saha SK, Roy S, Khuda-Bukhsh AR (2015) Ultra-highly diluted plant extracts of Hydrastis canadensis and Marsdenia condurango induce epigenetic modifications and alter gene expression profiles in HeLa cells in vitro . J Integra Med 13: 400-411.
  1. Thangapazham RL, Gaddipati JP, Rajeshkumar NV, Sharma A, Singh AK, et al. (2006) Homeopathic medicines do not alter growth and gene expression in prostate and breast cancer cells in vitro . Integr Cancer Ther 5: 356-361.
  1. Marzotto M, Olioso D, Brizzi M, Tononi P, Cristofoletti M, et al. (2014) Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-low doses of Gelsemium sempervirens. BMC Complement Altern Med 14: 104.
  1. Jonas WB, Gaddipati JP, Rajeshkumar NV, Sharma A, Thangapazham RL, et al. (2006) Can homeopathic treatment slow prostate cancer growth? Integr Cancer Ther 5: 343-349.
  1. Thangapazham RL, Rajeshkumar NV, Sharma A, Warren J, Singh AK, et al. (2006) Effect of homeopathic treatment on gene expression in Copenhagen rat tumor tissues. Integr Cancer Ther 5: 350-355.
  1. Chikramane PS, Suresh AK, Bellare JR, Kane SG (2010) Extreme homeopathic dilutions retain starting materials: A nanoparticulate perspective. Homeopathy 99: 231-242.
  1. Bell IR, Sarter B, Standish LJ, Banerji P, Banerji P (2015) Low Doses of Traditional Nanophytomedicines for Clinical Treatment: Manufacturing Processes and Nonlinear Response Patterns. J Nanosci Nanotechnol 15: 4021-4038.
  1. Upadhyay RP, Nayak C (2011) Homeopathy emerging as nanomedicine. Int J High Dilution Res 10: 299-310.
  1. Chikramane PS, Kalita D, Suresh AK, Kane SG, Bellare JR (2012) Why extreme dilutions reach non- zero asymptotes: a nanoparticulate hypothesis based on froth flotation. Langmuir 28: 15864-15875.
  1. Bell IR, Schwartz GE, Boyer NN, Koithan M, Brooks AJ (2013) Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health. Eur J Integr Med 5: 126-140.
  1. Bonamin LV, Martinho KS, Nina AL, Caviglia F, Do Rio RG (2001) Very high dilutions of dexamethasone inhibit its pharmacological effects in vivo . Br Homeopath J 90: 198-203.
  1. Montagnier L, Aïssa J, Ferris S, Montagnier JL, Lavallée C (2009) Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences. Interdiscip Sci 1: 81-90.

About the author

Arup Bhattacharya

Dr. Arup B Bhattacharya PhD, DHM, MS (Biophysics), MA(Psychology), DHM, Hom(ON), RSHom (NA), DHPh, PGDG studied homeopathy at the British Institute of Homeopathy and the International Academy of Classical Homeopathy. From 1992 to 1999, he was Director and the main spirit behind the Centre for Homoeopathic Cure, Dombivili, near Mumbai. He was involved in training and teaching homeopathy and now continues that passion in North America since 1999. Currently he lives in Buffalo, NY, USA and he teaches and practices classical homeopathy. He conducts regular seminars with live case taking for beginners and advanced practitioners. He was a faculty till his voluntary retirement in Sept 2018 in the Department of Cancer Chemoprevention and later in Department of Pharmacology and Therapeutics at one of the oldest NCI accredited top rated cancer centers in WNY – Roswell Park Comprehensive Cancer Center where he was also an advisor and Steering Committee Member for Wellness and Integrative Medicine Center. After retirement, he was requested to re-join and help with the ongoing effort to further the path breaking translational research involving the anticancer efficacy of the human protein prolidase. Arup regularly contributes to various prestigious scientific and homeopathic meetings and his work is published in prestigious peer reviewed scientific journals More details on him can be seen at www.homeopathichealers.com

About the author

Yuesheng Zhang

Dr. Yuesheng Zhang joined the faculty of Roswell Park Cancer Institute in 2003 and has been a Professor of Oncology since 2007. He has also been a Senior Member of the Roswell Park Graduate Division, the State University of New York Graduate College since 2003. He came to RPCI from the University of Arizona, Arizona Cancer Center, where he served as an Assistant Professor of Medicine.

Dr. Zhang earned his MD in 1984 and MS in 1988 from Zhejiang University School of Medicine (formerly Zhejiang Medical University, Hangzhou, China), and his PhD in Pharmacology and Molecular Sciences in 1996 from the Johns Hopkins University School of Medicine (Baltimore, USA), where he also completed postdoctoral fellowship and served as a junior faculty member.

Dr. Zhang is a member of the American Association for Cancer Research (AACR) and the American Society of Biochemistry & Molecular Biology (ASBMB). Dr. Zhang is also a member of the editorial boards of Molecular Cancer Therapeutics, Molecular Nutrition and Food Research, and Journal of Carcinogenesis and Mutagenesis.

Leave a Comment